Contact Jacoby & Meyers
Dangerous Drug Lawyers
Call us Today 800-977-5614

Adalimumab is an anti-inflammatory drug used to treat rheumatoid arthritis, Chron’s disease and other autoimmune diseases that cause severe inflammation. This medication doesn’t cure these conditions, but it can reduce painful symptoms associated with these conditions.
Warnings/Side Effects
Adalimumab has been associated with tuberculosis, a potentially fatal lung disease, in some patients. Patients need to have a tuberculosis test prior to their first prescription; any patient who currently has tuberculosis has to undergo anti-tuberculosis treatment before he or she can take Adalimumab. Some patients who do not have tuberculosis at the outset develop it while on this drug.
Children and adolescents who take this drug are at increased risk of lymphoma and other types of cancer. These diseases are often fatal.
Lawyer Advertising. This website is designed for general information only, and in no way is intended to constitute legal advice nor the formation of a lawyer/client relationship without a signed, written agreement. Testimonials or endorsements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. You pay no fees or costs unless we recover for you. This website contains dramatizations. Prior results are not a guarantee of a future outcome. Jacoby & Meyers does not accept all cases and works cooperatively with co-counsel and/or other law firms with whom it has joint agreements who might potentially handle your cases. We look forward to helping you with your claim.
© 2012-2023 Jacoby & Meyers. All rights reserved.